The Hartford Healthcare Fund Class R6 (HGHVX)

Fund Assets	1.02B
Expense Ratio	0.91%
Min. Investment	$2,000
Turnover	32.00%
Dividend (ttm)	1.90
Dividend Yield	4.36%
Dividend Growth	n/a
Payout Frequency	n/a
Ex-Dividend Date	Dec 11, 2024

Previous Close	43.26
YTD Return	0.17%
1-Year Return	1.76%
5-Year Return	26.24%
52-Week Low	43.56
52-Week High	52.82
Beta (5Y)	n/a
Holdings	108
Inception Date	Feb 28, 2019

About HGHVX

Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of health care-related companies worldwide as selected by the sub-adviser, Wellington Management Company LLP ("Wellington Management"). The fund takes a broad approach to investing in the health care sector. It may invest in health-related companies, including companies in the pharmaceuticals, biotechnology, medical delivery, medical products, medical services, managed health care, health information services and emerging health-related subsectors.

• Fund Family: Hartford Mutual Funds
• Category: Health
• Performance Rating: Average
• Risk Rating: Average
• Stock Exchange: NASDAQ
• Ticker Symbol: HGHVX
• Index: S&P Composite 1500 Health Care TR

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
HGHFX	Class F	0.91%
HGHIX	Class I	1.01%
HGHYX	Class Y	1.01%
HGHTX	Class R5	1.02%

Top 10 Holdings

45.67% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	10.97%
UnitedHealth Group Incorporated	UNH	9.62%
Merck & Co., Inc.	MRK	4.14%
Intuitive Surgical, Inc.	ISRG	3.92%
Boston Scientific Corporation	BSX	3.68%
Danaher Corporation	DHR	3.56%
Thermo Fisher Scientific Inc.	TMO	2.84%
Vertex Pharmaceuticals Incorporated	VRTX	2.73%
HCA Healthcare, Inc.	HCA	2.18%
Johnson & Johnson	JNJ	2.02%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 11, 2024	$1.89862	Dec 12, 2024
Dec 12, 2022	$0.36137	Dec 13, 2022
Dec 10, 2021	$4.37361	Dec 13, 2021
Dec 10, 2020	$5.16605	Dec 11, 2020
Dec 10, 2019	$2.36232	Dec 11, 2019